JPH0112759B2 - - Google Patents

Info

Publication number
JPH0112759B2
JPH0112759B2 JP58208444A JP20844483A JPH0112759B2 JP H0112759 B2 JPH0112759 B2 JP H0112759B2 JP 58208444 A JP58208444 A JP 58208444A JP 20844483 A JP20844483 A JP 20844483A JP H0112759 B2 JPH0112759 B2 JP H0112759B2
Authority
JP
Japan
Prior art keywords
residue
acid
trp
pro
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58208444A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59104350A (ja
Inventor
De Kasuteigurioone Roberuto
Gotsutsuiini Ruijia
Karuro Montekutsuchi Pieeru
Peruseo Giusetsupe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of JPS59104350A publication Critical patent/JPS59104350A/ja
Publication of JPH0112759B2 publication Critical patent/JPH0112759B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
JP58208444A 1982-11-10 1983-11-08 生物学的に活性なペプチド及びその製造方法，該ペプチドを含む動物用成長促進剤 Granted JPS59104350A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8232080 1982-11-10
GB8232080 1982-11-10
GB8310719 1983-04-20

Publications (2)

Publication Number Publication Date
JPS59104350A JPS59104350A (ja) 1984-06-16
JPH0112759B2 true JPH0112759B2 (mo) 1989-03-02

Family

ID=10534160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58208444A Granted JPS59104350A (ja) 1982-11-10 1983-11-08 生物学的に活性なペプチド及びその製造方法，該ペプチドを含む動物用成長促進剤

Country Status (3)

Country Link
JP (1) JPS59104350A (mo)
BE (1) BE898198A (mo)
ZA (1) ZA838315B (mo)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2513197B2 (ja) * 1986-01-21 1996-07-03 日本新薬株式会社 ピログルタミド誘導体
EP3916003A1 (en) * 2014-07-24 2021-12-01 Naurex, Inc. N-methyl-d-aspartate receptor modulators and methods of making and using same

Also Published As

Publication number Publication date
ZA838315B (en) 1984-06-27
BE898198A (fr) 1984-05-09
JPS59104350A (ja) 1984-06-16

Similar Documents

Publication Publication Date Title
US4100274A (en) Polypeptide
US6472505B1 (en) Peptide parathyroid hormone analogs
US4737487A (en) VIP type peptides
EP0148133B1 (en) Tripeptide compounds containing pyroglutamic acid and tryptophan, process for their production and therapeutic applications
US4086219A (en) Nonapeptides and methods for their production
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
US4386073A (en) Tripeptides acting on the central nervous system and a process for the preparation thereof
JPH0249800A (ja) ポリペプチド化合物、その製法並びにボンベシン又はボンベシン様ペプチドが仲介する疾患又は医学的症状を治療する製薬的組成物
EP0225020A2 (en) Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of ViP
HU182866B (en) Process for preparing new tetrapeptide derivatives
US4299821A (en) Tripeptides acting on the central nervous system and a process for the preparation thereof
US4124703A (en) Luliberin analogs
US4491541A (en) Peptides
GB2130590A (en) Peptides
US4111923A (en) Octapeptides and methods for their production
US4567162A (en) Biologically active heptapeptides
US3855198A (en) Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
FR2595705A1 (fr) Derives de gonadoliberine contenant un acide aminocarboxylique aromatique en position 6, compositions pharmaceutiques et veterinaires les contenant et procede pour les preparer
JPH03503165A (ja) 小さいサイズのｌｈｒｈ類似体
HU181402B (en) Process for preparing new peptides with psychopharmacological activity
JPS61143398A (ja) 動物成長促進剤
GB2109796A (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
WO1988005049A1 (en) Novel compounds
US4948873A (en) Gonadoliberine analogues of high activity
US4128540A (en) Pyroglutamyl-histidyl-tryptophanyl-seryl-tyrosyl hydrazides